Current FDA-approved prescribing information for semaglutide does not require routine thyroid monitoring, including serum calcitonin measurements or thyroid ultrasound surveillance, in patients without risk factors
You may be eligible if you have a BMI of 30+ or a BMI of 27+ with a weight-related condition like diabetes, high blood pressure, or high cholesterol
We do not know what happens at year two, or year five
While the absence of any substantially effective medication for assisting the treatment of CUD immediately brings attention to semaglutide's potential, the studys authors prudently conclude that Further preclinical studies are warranted to understand the underlying mechanism and randomized clinical trials are needed to support its use. We have no idea how semaglutide impacted obese and diabetic patients to decrease their cannabis use
The practical implication for dosing in units: if you are larger, you are more likely to reach higher doses, which means higher unit counts on your syringe
PMID: 31436480